DrugDashboards

Nystatin

Nystatin · NYSTATIN 100000 U/mL · Suspension · Oral · Kesin Pharma Corporation

NDC 81033-0015-60 · 1 BOTTLE in 1 CARTON / 60 mL in 1 BOTTLE · ANDA · View full market →

The short version

17 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for nystatin (other) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market · 1 Class I/II recall(s) in 12 months

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA062832
TE code
AA
Approval date
Dec 27, 1991
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Nystatin (Suspension)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsNYSTATIN 100000 [USP'U]/mLJul 15, 2026Sep 3, 2026
Pharmaceutical Associates, Inc.NYSTATIN 100000 [USP'U]/mLJul 15, 2026Sep 3, 2026
American Health PackagingNYSTATIN 100000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Bryant Ranch PrepackNYSTATIN 100000 U/mLJul 15, 2026Sep 2, 2026
Bryant Ranch PrepackNYSTATIN 100000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Chartwell Governmental & Specialty RX, LLCNYSTATIN 100000 U/mLJul 15, 2026Sep 2, 2026
Chartwell RX, LLCNYSTATIN 100000 U/mLJul 15, 2026Sep 2, 2026
Genus Lifesciences Inc.NYSTATIN 100000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Kanchan Healthcare IncNYSTATIN 100000 U/mLJul 15, 2026Sep 2, 2026
Leading Pharma, LLCNYSTATIN 100000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Major PharmaceuticalsNYSTATIN 100000 [USP'U]/mLJul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals,Inc.NYSTATIN 100000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc.NYSTATIN 100000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Xttrium Laboratories, Inc.NYSTATIN 100000 [USP'U]/mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCNYSTATIN 100000 [USP'U]/mLJul 15, 2026Aug 31, 2026
PAI Holdings, LLC dba PAI PharmaNYSTATIN 100000 [USP'U]/mLJul 15, 2026Aug 31, 2026
Atlantic Biologicals Corp.NYSTATIN 100000 [USP'U]/mLJul 15, 2026Aug 29, 2026
Kesin Pharma CorporationNYSTATIN 100000 U/mLJul 15, 2026Aug 28, 2026
Taro Pharmaceuticals U.S.A., Inc.NYSTATIN 100000 [USP'U]/mLJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Nystatin — NDC 81033-0015-60," retrieved September 3, 2026, https://drugdashboards.com/drug/81033001560.

Free to cite with attribution — see how the data is put together.